Condition: Prostate Cancer · Sponsor: St. Antonius Hospital
The goal of this clinical trial is to evaluate the safety and effectiveness of a novel diagnostic strategy for prostate cancer, in which men with a moderate risk of prostate cancer are monitored using PSA and MRI instead of immediate biopsy,. The main questions it aims to answer are: * Is it safe to delay biopsy, making sure that clinical significant prostate cancers are not often missed? * Does it reduce unnecessary biopsies and overtreatment?
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Treant | Emmen, Drenthe, Netherlands | Recruiting |
| Andros Clinics | Arnhem, Gelderland, Netherlands | Recruiting |
| Radboud University Medical Centre | Nijmegen, Gelderland, Netherlands | Recruiting |
| Canisius Wilhelmina Hospital | Nijmegen, Gelderland, Netherlands | Recruiting |
| Antoni van Leeuwenhoek Hospital | Amsterdam, North Holland, Netherlands | Recruiting |
| Maasstad Hospital | Rotterdam, South Holland, Netherlands | Not Yet Recruiting |
| St Antonius Hospital | Nieuwegein, Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07180381